Steven J. Fleischman, MD, MBA, FACOG, president of the American College of Obstetricians and Gynecologists released remarks on analgesic safety for patients who are pregnant.
A recent study found that pregnant women with high anxiety and depression symptoms exhibited a richer oral microbiome, suggesting potential ways to improve maternal psychological well-being.
Recent study links tibolone use in menopausal hormone therapy to a 52% increased cardiovascular disease risk, emphasizing the need for tailored hormone therapy approaches and further research in BMJ.
"As we continue to learn about the potential harms and benefits of prenatal cannabis use, clinicians must provide coordinated, nonstigmatizing care and education to support pregnant individuals in making informed decisions about cannabis use," noted study authors.